References:
[1] Magalhães T N C,Weiler M,Teixeira C V L,et al. Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease[J]. Molecular Neurobiology,2018,55(7): 5689-5697.
[2] Shen X,Niu L,Wang Y,et al. Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies[J]. Journal of Neurology, Neurosurgery & Psychiatry,2019,90(5): 590-598.
[3] Fang Y,Du N,Xing L,et al. Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article[J]. Medicine (Baltimore),2019, 98(30): e16604.
[4] Palmqvist S,Janelidze S,Stomrud E.et al. Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related-Amyloid Status[J]. JAMA Neurol,2019,76(9): 1060-1069.